Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

6.3%

1 terminated/withdrawn out of 16 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

25%

4 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
8(53.3%)
Phase 2
3(20.0%)
Phase 4
2(13.3%)
Phase 3
2(13.3%)
15Total
N/A(8)
Phase 2(3)
Phase 4(2)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT07356284Phase 3Not Yet Recruiting

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

Role: lead

NCT06949228Phase 2Recruiting

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial

Role: lead

NCT06927245Not ApplicableNot Yet Recruiting

Use of the PTEye Device to Reduce Inadvertent Parathyroidectomy During Thyroid Surgery

Role: lead

NCT05172934Phase 2Completed

Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial

Role: lead

NCT05175547Phase 3Completed

Clevidipine Infusion for Blood Pressure Management After Successful Revascularization in Acute Ischemic Stroke

Role: lead

NCT04440475Not ApplicableCompleted

Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy

Role: lead

NCT05633277Not ApplicableUnknown

Outcomes of Sclerotherapy of the Ulcer Bed Compared to a Combination of Ablation and Injections

Role: lead

NCT04635696Phase 4Completed

Ethyl Chloride for NPWT

Role: lead

NCT03355248Not ApplicableCompleted

Satisfaction Following Cesarean Section

Role: lead

NCT03026205Phase 2Withdrawn

ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC)

Role: collaborator

NCT01854138Not ApplicableCompleted

Evaluating Advantages of Prevena After Hip and Knee Arthroplasty

Role: lead

NCT02040675Completed

Use of NAVA-catheter Positioning Screen to Identify Different Cardiac Arrhythmias

Role: lead

NCT02048280Not ApplicableCompleted

Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support

Role: lead

NCT01755299Not ApplicableCompleted

Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels

Role: lead

NCT01485718Phase 4Unknown

Effect of Daily Glucomannan in Overweight Patients

Role: lead

NCT00985361Not ApplicableCompleted

Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus

Role: lead

All 16 trials loaded